Skip to content

Clinical trials

Completed Adenocarcinoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Completed Country / region: Canada Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20053
20062
20081
20092
20103
20122
20131
20142
20152
20164
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto4
Eli Lilly and Company3
Abbott1
Ariad Pharmaceuticals1
Boehringer Ingelheim1
Celgene1
Clovis Oncology, Inc.1
Dr. Gordon Buduhan1
Genzyme, a Sanofi Company1
Imunon1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma25
Neoplasms9
Carcinoma, Non-Small-Cell Lung7
Carcinoma, Squamous Cell5
Lung Neoplasms4
Pancreatic Neoplasms4
Carcinoma3
Digestive System Diseases3
Digestive System Neoplasms3
Neoplasms by Site3

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.